This document, used in this podcast provides the complete prescribing information for Kesimpta (ofatumumab), a subcutaneous injection indicated for treating relapsing multiple sclerosis in adults. It details dosage, administration, contraindications (including active HBV infection and ofatumumab hypersensitivity), and warnings and precautions (such as infection risk, injection reactions, and fetal harm). Adverse reactions, drug interactions, and use in specific populations are also addressed. The document includes instructions for use for both the pre-filled pen and syringe. Finally, a patient counseling information section is provided to advise patients on potential risks and proper usage.